The Move to Value-based Care in Oncology: OCM and ASCO

Over forty commercial payers submitted Letters of Intent indicating an interest in CMS’s Oncology Payment Model (OCM) in 2015. This precipitated sharp disagreement between CMS and ASCO on how value-based payments in Oncology should be addressed

Oncology Payment Model Reform

Payment reforms in Oncology are complicated by different measures of cost effectiveness and high-cost specialty drugs. This module which explores the pros and cons of the OCM and ASCO alternative reimbursement methodologies by discussing the following:

  • The differences between the ASCO and OCM payment methodologies
  • The impact each payment methodology has on provider reimbursement
  • How each payment methodology may impact provider decision-making

Let us do the heavy lifting!

We connect the dots across the Healthcare Ecosystem from lots of different sources to make your job easier for you, the healthcare decision-maker. You already have enough to worry about. We want you to think about solutions to big problems, not about how to find data to answer questions.